Contrave Extended-Release 90 mg/1
naltrexone hydrochloride and bupropion hydrochloride · TABLET, EXTENDED RELEASE · Nalpropion Pharmaceuticals LLC
Contrave is a prescription tablet containing naltrexone and bupropion that is used to help with weight management in adults. It works by acting on areas of the brain that control hunger and energy expenditure.
Key Facts
- Brand Name
- Contrave Extended-Release
- Generic Name
- naltrexone hydrochloride and bupropion hydrochloride
- NDC Code (Product)
51267-890- Manufacturer
- Nalpropion Pharmaceuticals LLC
- Strength
- 90 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA200063
- Marketing Start
- 10/22/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Contrave Extended-Release used for?
Contrave is a prescription tablet containing naltrexone and bupropion that is used to help with weight management in adults. It works by acting on areas of the brain that control hunger and energy expenditure.
Is Contrave Extended-Release a controlled substance?
Contrave Extended-Release is not classified as a controlled substance by the DEA.
What is the generic name for Contrave Extended-Release?
The generic name for Contrave Extended-Release is naltrexone hydrochloride and bupropion hydrochloride. There are no other listed brand versions of naltrexone hydrochloride and bupropion hydrochloride.
What is the NDC code for Contrave Extended-Release 90 mg/1?
The NDC (National Drug Code) for Contrave Extended-Release 90 mg/1 is 51267-890, listed by Nalpropion Pharmaceuticals LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)